Silent Echoes: An In-Depth Qualitative Analysis of Benzodiazepine Misuse Patterns, Motivations, and Consequences Among Italian Young Adults

Background
In recent years, the misuse of benzodiazepines (BZDs) has significantly increased, emerging as a critical global health and social issue. This trend is largely driven by the increased accessibility of BZDs through online platforms and the profound impact of the COVID-19 pandemic.
Objective
This study aims to provide a comprehensive overview of BZD misuse trends among Italian youths, exploring factors, such as internet influence, perceived safety, pandemic effects, and potential psychological interventions through a qualitative analysis.
Methods
The study employed a non-probabilistic sampling method, recruiting 28 participants aged 18–35 with a history of BZD misuse. Data were gathered through semi-structured interviews lasting 45–60 min, focusing on experiences and motivations related to BZD use, including self-medication, recreational use, and the impact of the COVID-19 pandemic.
Results
Thematic analysis revealed that 67.9% of participants used BZDs without a prescription, primarily for anxiety relief. The COVID-19 pandemic significantly influenced usage patterns, with 71.4% reporting increased consumption during lockdowns. Although most participants recognized the need for psychological support, few actively sought professional help. Online accessibility emerged as a key factor in misuse behavior, even though 85.7% of participants were aware of the associated risks (e.g., dependence, cognitive impairment, and overdose). The main motivations for BZD misuse were self-medication for untreated psychological distress and, to a lesser extent, recreational purposes, such as enhancing social interaction or emotional detachment.
Conclusion
This research highlights the complex phenomenon of BZD misuse among youths, emphasizing the interplay between internet accessibility, pandemic-related stressors, and psychological needs. Despite the limited number of participants, the findings suggest the need for accessible mental health support and targeted education on the risks associated with BZDs.
- Moore TJ, Mattison DR. Adult utilization of psychiatric drugs and differences by sex, age, and race. JAMA Intern Med. 2017;177(2):274-275. doi: 10.1001/jamainternmed.2016.7507
- Center for Behavioral Health Statistics and Quality. National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration. Rockville, MD: Center for Behavioral Health Statistics and Quality; 2017.
- Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: A systematic review. Drug Alcohol Depend. 2019;200:95- 114. doi: 10.1016/j.drugalcdep.2019.02.033
- The Medicines Utilisation Monitoring Centre. National Report on Medicines Use in Italy. Year 2019. Italy: Italian Medicines Agency; 2020.
- European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2021: Trends and Developments. Publications Office of the European Union; 2021.
- Edinoff AN, Nix CA, Hollier J, et al. Benzodiazepines: Uses, dangers, and clinical considerations. Neurol Int. 2021;13(4):594-607. doi: 10.3390/neurolint13040059
- Lader M. Benzodiazepines revisited -will we ever learn? Addiction. 2011;106(12):2086-2109. doi: 10.1111/j.1360-0443.2011.03563.x
- Jones CM, Paulozzi LJ, Mack KA, Centers for Disease Control and Prevention. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths - United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(40):881-885.
- Abouchedid R, Gilks T, Dargan PI, Archer JRH, Wood DM. Assessment of the availability, cost, and motivations for use over time of the new psychoactive substances-benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam-in the UK. J Med Toxicol. 2018;14(2):134-143. doi: 10.1007/ s13181-018-0659-3
- Schifano F, Orsolini L, Papanti GD, Corkery JM. Novel psychoactive substances of interest for psychiatry. World Psychiatry. 2015;14(1):15-26. doi: 10.1002/wps.20174
- Nautiyal A. Drug abuse & cognitive functioning. Ment Health Hum Resil Int J. 2023;7(2):1-11. doi: 10.23880/mhrij-16000227
- Collatuzzo G, Gabbiadini A, Martins S, Boffetta P. Inappropriate benzodiazepine medical and non-medical use: A neglected problem begging for prevention. Top Ital Sci J. 2025;2(1): 4-5. doi: 10.62684/TIIK3824
- Arnett JJ. Emerging Adulthood: The Winding Road from the Late Teens through the Twenties. Oxford: Oxford University Press; 2014.
- Chen YT, Liu CY, Chang CM, Lin YY, Tsai CF, Wang LJ. Perceptions, clinical characteristics, and other factors associated with prolonged and high daily dose of benzodiazepine use among patients with anxiety or depressive disorders. J Affect Disord. 2020;271:215-223. doi: 10.1016/j.jad.2020.03.077
- Orsolini L, Francesconi G, Papanti D, Giorgetti A, Schifano F, Corkery JM. Profiling online recreational/prescription drugs’ customers and overview of drug vending virtual marketplaces. Hum Psychopharmacol. 2014;29(4):286-293. doi: 10.1002/hup.2403
- Peteet B, Roundtree C, Dixon S, Stanley C, Edwards M, Moss D. “Codeine crazy:” A content analysis of prescription drug references in popular music. J Youth Stud. 2021;24(8):1100-1116. doi: 10.1080/13676261.2020.1801992
- Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77-101. doi: 10.1191/1478088706qp063oa
- Baldwin DS, Polkinghorn C. Evidence-based pharmacotherapy of generalized anxiety disorder. Int J Neuropsychopharmacol. 2015;18(7):pyv018. doi: 10.1093/ijnp/pyv018
- Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med. 2018;378(8):693-695. doi: 10.1056/NEJMp1715050
- Norman A, Leung M, Burgess M. The rise of online prescription drug purchases among adolescents: A growing concern. J Adolesc Health. 2020;66(2):234-240. doi: 10.1016/j. jadohealth.2019.07.001
- JAMA Network. Trends in benzodiazepine prescribing for US adolescents and young adults. JAMA. 2022;327(1):69-71. doi: 10.1001/jama.2021.23210
- American Academy of Pediatrics. Severe benzodiazepine use disorder in a 16-year-old adolescent: A rapid deterioration case. Pediatrics. 2020;146(2):e20201234. doi: 10.1542/ peds.2020-1234
- Andersson JA. Acute poisoning related to benzodiazepine substance abuse in patients at Oslo’s main emergency clinic. J Subst Abuse Treat. 2020;110:9-15. doi: 10.1016/j.jsat.2019.12.002
- Liebrenz M. Reasons for benzodiazepine abuse among adults: A qualitative analysis. J Subst Use Misuse. 2015;50(8):1042-1051. doi: 10.3109/10826084.2015.1007662
- Sarker A, Molla AR, Ge Y, et al. Evidence of the emergence of illicit benzodiazepines from online drug forums. Int J Drug Policy. 2022;89:103066. doi: 10.1016/j.drugpo.2020.103066